Preclinical studies consistently demonstrate that the imbalance between the pro-tumor ACE/AngII/AT1R axis and the anti-tumor ACE2/Ang(1-7)/MasR axis promotes angiogenesis, cell proliferation, and metastasis [41,44]. This evidence concerns the gene MAS1L and neoplasm.